REFACTO
REFACTO
Discontinued
DIN Number
02245951
Drug Class
Human
Market Date
Feb 11, 2003
Company
HC
wyeth canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245951
AIG Number0147521001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
MOROCTOCOG ALFAActive
Strength: 1000 UNIT / VIAL
Monograph: MOROCTOCOG ALFA